London has secured second place in a ranking of 1,000 global destinations, but its housing affordability crisis is significantly undermining its overall appeal to workers and residents. The latest Global Cities Index
More
Power Probe chief executive Chema Garcia says he remains committed to the company’s London listing despite a sharp fall in its share price since debuting on the Aim market. The North Carolina-based
More
The Organisation for Economic Co-operation and Development has published a new guidance document addressing toxicokinetics testing specifically designed to accommodate the study of (nano)particles. Posted on August 10, 2026, the document provides
More
New York State has enacted a landmark law giving employees the right to inspect their personnel records, effective November 8, 2026. Governor Kathy Hochul signed Senate Bill S3460 on September 9, 2026,
More
The United States Supreme Court, one of the most powerful institutions in the world, spent the majority of its early history without a permanent home of its own. Before securing a dedicated
More
Weil insiders have made little effort to conceal their indifference toward the departure of Mike Aiello, one of the firm’s most prominent partners. The reaction from within the firm has been notable
More
Chevron (NYSE: CVX) remains one of the most closely watched names in the diversified upstream exploration and production sector heading into mid-2026. The company operates across a broad range of geographies, giving
More
The FTSE 100 rose at the start of a pivotal week for global monetary policy, with defensive stocks leading gains across the index. Investors rotated into traditionally safer sectors as markets braced
More
Business leaders are pressing Chancellor John Healey to reverse inheritance tax reforms they say are actively damaging family-run companies across the United Kingdom. A coalition of top industry bodies, representing more than
More
Novo Nordisk is streamlining its public identity, adopting “Novo” as its everyday brand name while retaining Novo Nordisk A/S as its legal global company name. The move places the Danish pharmaceutical giant
More